These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10641113)

  • 1. [Graves' ophthalmopathy--a prospective clinical study].
    Bogdănici C; Marcu C
    Oftalmologia; 1999; 48(3):19-22, 25. PubMed ID: 10641113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic Graves' disease.
    Mornex R; Fournier G; Berthezene F
    Mod Probl Ophthalmol; 1975; 14():426-31. PubMed ID: 1242209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
    Bednarek J; Wysocki H; Sowiński J
    Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine receptor antibodies in patients with Graves' ophthalmopathy.
    Jacobson DM
    J Neuroophthalmol; 1995 Sep; 15(3):166-70. PubMed ID: 8574362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' ophthalmopathy.
    Bistriceanu M; Cergă A; Lichiardopol-Răducanu C
    Oftalmologia; 1993; 37(2):99-103. PubMed ID: 8507632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbital lymphoma masquerading as thyroid ophthalmopathy.
    Boyce PJ
    J Am Optom Assoc; 1998 Oct; 69(10):666-73. PubMed ID: 9805448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
    Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' disease of the orbit.
    Weber AL; Dallow RL; Sabates NR
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical analysis of Graves' ophthalmopathy and ophthalmic Graves' disease].
    Liao ZQ
    Zhonghua Yan Ke Za Zhi; 1992 Jul; 28(4):236-9. PubMed ID: 1299571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postural variation of exophthalmometry in Graves' ophthalmopathy.
    Asad R; Tewari HK; Ahuja MM; Mithal A
    Indian J Ophthalmol; 1990; 38(4):166-8. PubMed ID: 2086467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM; Prummel MF; Wiersinga WM
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of urinary mucopolysaccharides in Graves' disease.
    Ursu H; Dumitrescu C; Bartoc R; Dumitriu L
    Endocrinologie; 1984; 22(4):277-82. PubMed ID: 6240765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroidectomy remains an effective treatment option for Graves' disease.
    Weber KJ; Solorzano CC; Lee JK; Gaffud MJ; Prinz RA
    Am J Surg; 2006 Mar; 191(3):400-5. PubMed ID: 16490555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease.
    Bufalo NE; Santos RB; Cury AN; Andrade RA; Morari J; Morari EC; Leite JL; Monte O; Romaldini JH; Ward LS
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):982-7. PubMed ID: 17980001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves' thyroid ophthalmopathy in Ethiopian patients.
    Teshome T; Seyoum B
    Ethiop Med J; 2001 Jan; 39(1):1-8. PubMed ID: 11338463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
    Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
    Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.